In summary, we demonstrated that oxoglaucine significantly suppresses TGFβ-induced hepatic fibrosis, and that regulation of Smad7 levels is an important factor in the inhibition of Smad2 phosphorylation. This evidence concerns the gene SMAD7 and Hepatic fibrosis.